Physician profile
Mary R Mauck
NPI 1326465998
$986.59
in general payments reported to CMS, 2019-2025
14 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Acute Care (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $137).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.00 · 2022: $12.58 · 2023: $116 · 2024: $478 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $335.96 | 2023-2024 | |
| Pfizer INC. | $129.63 | 2023-2025 | |
| Edwards Lifesciences Corporation | $121.37 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals Lp | $70.59 | 2024-2025 | Farxiga, Lokelma, Wainua |
| Scpharmaceuticals INC. | $51.87 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.05 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $45.25 | 2025 | |
| Heartflow, INC. | $44.96 | 2024 | |
| Janssen Pharmaceuticals, INC | $38.00 | 2021 | |
| Merck Sharp & Dohme LLC | $29.96 | 2025 | Verquvo |
| Atricure, INC. | $21.92 | 2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Cleerly, INC. | $21.49 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Lexicon Pharmaceuticals, INC. | $16.96 | 2024 | |
| Angiodynamics, INC. | $12.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Mauck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.